218
Views
2
CrossRef citations to date
0
Altmetric
Imaging

Variability of clinical syndromes and cerebral glucose metabolism in symptomatic frontotemporal lobar degeneration associated with progranulin mutations

, , , , , , , & ORCID Icon show all
Pages 389-395 | Received 03 Jan 2020, Accepted 03 Jun 2020, Published online: 22 Jun 2020

References

  • Wauters E, Van Mossevelde S, Van der Zee J, Cruts M, Van Broeckhoven C. Modifiers of GRN-associated frontotemporal lobar degeneration. Trends Mol Med. 2017;23:962–79.
  • Young JJ, Lavakumar M, Tampi D, Balachandran S, Tampi RR. Frontotemporal dementia: latest evidence and clinical implications. Ther Adv Psychopharmacol. 2018;8:33–48.
  • Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916–9.
  • Galimberti D, Fumagalli GG, Fenoglio C, Cioffi SMG, Arighi A, Serpente M, et al. Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study. Neurobiol Aging. 2018;62:245.e9–e12.
  • Wauters E, Van Mossevelde S, Sleegers K, van der Zee J, Engelborghs S, Sieben A, et al. Clinical variability and onset age modifiers in an extended Belgian GRN founder family. Neurobiol Aging. 2018;67:84–94.
  • Jacova C, Hsiung GY, Tawankanjanachot I, Dinelle K, McCormick S, Gonzalez M, et al. Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers. Neurology. 2013;81:1322–31.
  • Caroppo P, Habert MO, Durrleman S, Funkiewiez A, Perlbarg V, Hahn V, et al. Lateral temporal lobe: an early imaging marker of the presymptomatic GRN disease? J Alzheimers Dis. 2015;47:751–9.
  • Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, et al. The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology. 1993;43:2457–65.
  • Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412–4.
  • Knopman D, Kramer J, Boeve B, Caselli R, Graff-Radford N, Mendez M, et al. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain. 2008;131:2957–68.
  • Zech M, Boesch S, Maier EM, Borggraefe I, Vill K, Laccone F, et al. Haploinsufficiency of KMT2B, encoding the lysine-specific histone methyltransferase 2B, results in early-onset generalized dystonia. Am J Hum Genet. 2016;99:1377–87.
  • Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
  • Friston K, Holmes A, Worsley K, Poline J-P, Frith C, Frackowiak R. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp. 1994;2:189–210.
  • Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.
  • Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–14.
  • Mackenzie IR. The neuropathology and clinical phenotype of FTD with progranulin mutations. Acta Neuropathol. 2007;114:49–54.
  • Scheltens NME, van der Weijden K, Adriaanse SM, van Assema D, Oomen PP, Krudop WA, et al. Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease. Neuroimage Clin. 2018;19:625–32.
  • Fumagalli GG, Basilico P, Arighi A, Bocchetta M, Dick KM, Cash DM, et al. Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales. Alzheimer’s Res Ther. 2018;10:46.
  • Cash DM, Bocchetta M, Thomas DL, Dick KM, van Swieten JC, Borroni B, et al. Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study. Neurobiol Aging. 2018;62:191–6.
  • Premi E, Cauda F, Gasparotti R, Diano M, Archetti S, Padovani A, et al. Multimodal FMRI resting-state functional connectivity in granulin mutations: the case of fronto-parietal dementia. PLoS One. 2014;9:e106500.
  • Whitwell JL, Xu J, Mandrekar J, Boeve BF, Knopman DS, Parisi JE, et al. Frontal asymmetry in behavioral variant frontotemporal dementia: clinicoimaging and pathogenetic correlates. Neurobiol Aging. 2013;34:636–9.
  • Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain. 2006;129:3081–90.
  • Gliebus G, Bigio EH, Gasho K, Mishra M, Caplan D, Mesulam MM, et al. Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation. Neurology. 2010;74:1607–10.
  • Kim G, Ahmadian SS, Peterson M, Parton Z, Memon R, Weintraub S, et al. Asymmetric pathology in primary progressive aphasia with progranulin mutations and TDP inclusions. Neurology. 2016;86:627–36.
  • Clark D, Boutros N, Mendez M. Occipital and parietal lobes. In: Clark D, Boutros N, Mendez M, editors. The brain and behavior. Cambridge University Press; 2009, Cambridge.
  • Rohrer JD, Ridgway GR, Modat M, Ourselin S, Mead S, Fox NC, et al. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage. 2010;53:1070–6.
  • Minkova L, Habich A, Peter J, Kaller C, Eickhoff S, Klöppel S. Gray matter asymmetries in aging and neurodegeneration: a review and meta-analysis. Hum Brain Mapp. 2017;38:5890–904.
  • Mesulam MM, Weintraub S, Rogalski EJ, Wieneke C, Geula C, Bigio EH. Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. Brain. 2014;137:1176–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.